Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001586785-26-000006

Chief Executive Officer acquired 100,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

NEIL GARRY ARTHUR · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-05-21 Grant or award : show line 1 in the form +100,200 190,314 D
Loading xslF345X06/form4-05262026_040501.xml…